The US FDA has announced that it is approving Jakafi (ruxolitinib) to treat a rare type of Bone Marrow disease known as Polycythemia vera. The disease actually causes an excess of RBC’s in the Bone Marrow. The increase in RBC also leads to a spike in other components of the blood like the platelets and […]
Home » Polycythemia vera